Ann: Halucenex Expands its Clinical Trials Plans, page-9

I'm sencing a few market jitters. Might be some significant June selling across the board (happens regularly) to manage tax planning. Then profit takers in July August (new tax year) as well as those picking back up the stock they sold in 2021 tax year. It seems a lot of selling for the next 3 months will have more to do with tax structuring than company fundamentals. That said, any remarkable announcements will be welcomed and acted upon.